Sunday, April 26, 2026 | 09:28 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Biocon Ltd Quarterly Results

Q3 FY25-26 Results Summary

Revenue

The revenue stands at ₹4,173.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.85 per cent from ₹4,295.50 crore. This corresponds to a year-on-year *(YoY) growth of 9.20 per cent.

Operating Profit

Operating Profit stands at ₹540.10 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 34.41 per cent from ₹823.50 crore. This corresponds to a year-on-year *(YoY) decline of 28.16 per cent.

PBDT

PBDT stands at ₹447.50 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 30.54 per cent from ₹644.30 crore. This corresponds to a year-on-year *(YoY) decline of 23.02 per cent.

Profit Before Tax

Profit Before Tax stands at ₹-67.80 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 139.58 per cent from ₹171.30 crore. This corresponds to a year-on-year *(YoY) decline of 143.49 per cent.

Net Profit

Net Profit stands at ₹-51.80 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 139.01 per cent from ₹132.80 crore. This represents a 163.87 per cent year-on-year *(YoY) decline for the same year.

  • YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Biocon Ltd Earnings

Data not available

Biocon Ltd Earning Charts

Revenue from Operations

in ₹ cr

EBITDA

in ₹ cr

Profit before Tax

in ₹ cr

Net Profit

in ₹ cr

Biocon Ltd Research Reports

ActionTarget Price (₹)BrokerDateReports
Buy 480Edelweiss Securities09-Dec-2025
Buy 476JM Financial08-Dec-2025
Buy 424JM Financial11-Aug-2025
Buy 430Motilal Oswal13-Jan-2025
Sell 235ICICI Securities12-Aug-2024

Biocon Ltd Financial Reports

Filter By:
Loading...

Biocon Ltd Stock Prices Compare with Peers

Company1 Day1 Week1 month3 month6 month1 Year
Biocon-2.28%-2.47%-5.53%-4.27%-2.82%9.04%
Glenmark Pharma.-1.68%3.07%5.88%14.84%26.81%63.13%
Alkem Lab-5.48%-7.21%-2.15%-9.14%-4.43%4.11%
Laurus Labs-1.37%-1.43%10.32%11.39%18.38%77.75%
Abbott India-0.79%-1.49%-3.66%-8.98%-15.39%-15.30%
Glaxosmi. Pharma-0.47%1.68%9.47%5.73%-7.95%-13.19%
Anthem Bioscienc-0.07%2.18%8.56%24.90%0.91%1.25%

Company Info

Company Information

Chairperson : Kiran Mazumdar Shaw

Non Executive Director : Ravi Mazumdar

Independent Director : Bobby Parikh

Non Executive Director : Eric Vivek Mazumdar

Lead Independent Director : Naina Lal Kidwai

Independent Director : Atul Dhawan

Independent Director : Rekha Mehrotra Menon

Independent Director : NICHOLAS ROBERT HAGGAR

Company Sec. & Compli. Officer : Ekta Agarwal

Managing Director & Chief Executive Officer : Shreehas Pradeep Tambe

Biocon Ltd News

Data Not Available